FSTL1 and lung adenocarcinoma: Decreased levels of FSTL1 have been found in various tumors compared to normal tissues and have been associated with poor clinical prognosis in patients with ovarian cancer, non-small cell lung cancer, especially with lung adenocarcinoma [20,32,78].